Researchers identify lethal molecular alterations after current therapies fail patients with metastatic melanoma

In a new translational study from UCLA Jonsson Comprehensive Cancer Center, researchers analyzed genetic changes in the organs of recently deceased patients to understand how metastatic cutaneous melanoma spreads in those who had initially benefited from precision therapies. Results are published online ahead of print in Nature Medicine.

Leave A Comment

Your email address will not be published. Required fields are marked *